How Conte was paid
$875,320 in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Other | Total |
|---|---|---|---|---|---|---|
| Lisa A. ContePresident & Chief Executive Officer | $582,282 | $85,429 | $21,289 | $160,166 | $26,154 | $875,320 |
| Pravin Chaturvedi, Ph.D.Chief Scientific Officer | $470,271 | $70,235 | $6,349 | $47,771 | $52,001 | $646,627 |
| Steven R. King, Ph.D.Chief, Sustainable Supply, Ethnobotanical Research & Intellectual Property | $356,517 | $54,333 | $6,349 | $47,771 | $50,932 | $515,002 |
| Jonathan WolinChief of Staff, General Counsel & Chief Compliance Officer | $400,584 | $58,935 | $6,349 | $47,771 | $60,568 | $574,208 |
What changed and why
- $875K$875,320 was CEO Lisa A. Conte’s 2024 total compensation, versus $815,854 in 2023.
- $600K$600,005 was Conte’s annualized base salary effective October 1, 2024, up from $576,374.
- $160K$160,166 in option awards and $21,289 in stock awards were reported for Conte in 2024.
- $85,429$85,429 was Conte’s 2024 bonus, while all other compensation was $26,154.
- $47,771$47,771 in option awards and $6,349 in stock awards were reported for each of the other three NEOs.
- $300$300 was paid to each NEO for cancellation of certain unvested options in December 2022.
Other Jaguar Health proxy statements
- 2026 proxy statement
Lisa A. Conte paid $705,675 (-19% on the year).
Filed Apr 30, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.